Combined oral contraceptives and venous thromboembolism: review and perspective to mitigate the risk

L Morimont, H Haguet, JM Dogné, U Gaspard… - Frontiers in …, 2021 - frontiersin.org
Many factors must be considered and discussed with women when initiating a contraceptive
method and the risk of venous thromboembolism (VTE) is one of them. In this review, we …

History of oral contraceptive drugs and their use worldwide

S Christin-Maitre - Best practice & research Clinical endocrinology & …, 2013 - Elsevier
The first hormonal pill, called Enovid®, was approved by the Federal Drug Administration
(FDA) in May 1960. It contained mestranol and norethisterone. Over the years, oral …

Pharmacokinetics, metabolism and serum concentrations of progestins used in contraception

AJ Bick, R Louw-du Toit, SB Skosana… - Pharmacology & …, 2021 - Elsevier
Many different forms of hormonal contraception are used by millions of women worldwide.
These contraceptives differ in the dose and type of synthetic progestogenic compound …

[HTML][HTML] Choosing a combined oral contraceptive pill

M Stewart, K Black - Australian prescriber, 2015 - ncbi.nlm.nih.gov
The combined oral contraceptive pill is an effective contraceptive method which can also
offer other benefits. However, other contraceptive options should be discussed. If the pill is …

Venous thrombotic risk in transgender women undergoing estrogen therapy: a systematic review and metaanalysis

J Khan, RL Schmidt, MJ Spittal, Z Goldstein… - Clinical …, 2019 - academic.oup.com
BACKGROUND Transgender women are female individuals who were recorded men at
birth based on natal sex. Supporting a person's gender identity improves their psychological …

Hormonal and natural contraceptives: a review on efficacy and risks of different methods for an informed choice

AR Genazzani, T Fidecicchi, D Arduini… - Gynecological …, 2023 - Taylor & Francis
The debate about contraception has become increasingly important as more and more
people seek safe and effective contraception. More than 1 billion women of reproductive age …

Use of oral contraceptives for management of acne vulgaris and hirsutism in women of reproductive and late reproductive age

R Słopień, E Milewska, P Rynio… - Menopause Review …, 2018 - termedia.pl
Hormonal contraception in both reproductive and late reproductive age, as well as
contraceptive action, is used also for other indications like dysmenorrhoea, menstrual …

Oestrogen component of COCs: have we finally found a replacement for ethinyl estradiol?

AJ Voedisch, WK Fok - Current Opinion in Obstetrics and …, 2021 - journals.lww.com
Oestrogen component of COCs: have we finally found a replace... : Current Opinion in Obstetrics
and Gynecology Oestrogen component of COCs: have we finally found a replacement for …

Pooled analysis of bleeding profile, efficacy and safety of oral oestradiol valerate/dienogest in women aged 25 and under

JT Jensen, J Bitzer, RE Nappi, C Ahlers… - … European Journal of …, 2020 - Taylor & Francis
Purpose: To evaluate differences in key outcomes between younger and older women
receiving the oral contraceptive oestradiol valerate/dienogest (E2V/DNG). Methods: We …

β-estradiol 17-valerate affects embryonic development and sexual differentiation in Japanese medaka (Oryzias latipes)

B Lei, J Kang, Y Yu, J Zha, W Li, Z Wang - Aquatic toxicology, 2013 - Elsevier
β-estradiol 17-valerate (EV) is a synthetic estrogen widely used in combination with other
steroid hormones in hormone replacement therapy drugs and is detected in natural waters …